Analysis of Serum Creatinine Levels, Blood Pressure and Grade of Hypertension of Chronic Disease Management Program Participants

Authors

  • Asbar Tanjung Department of Medical Laboratory Technology, STIKes Prima Indonesia
  • Ika Nurhidayah Department of Medical Laboratory Technology, STIKes Prima Indonesia
  • Sharfina Maulidayanti Department of Medical Laboratory Technology, STIKes Prima Indonesia
  • Ing Mayfa Br Situmorang Department of Medical Laboratory Technology, STIKes Prima Indonesia

DOI:

https://doi.org/10.31964/mltj.v10i2.619

Keywords:

Creatinine levels, correlation, hypertension

Abstract

Indonesia is one of the countries with the highest number of cases of hypertension in the world; the predominant patient is the elderly. In some patients with hypertension, increased blood pressure causes impaired salt and creatinine excretion, resulting in poor kidney function. A chronic disease management program is a health care system with a proactive-integrative approach to prevent further complications. The research objective is to analyze serum creatinine levels, blood pressure, and hypertension grade and determine the relationship between serum creatinine and blood pressure in chronic disease management program participants. The study subjects, 73 participants with hypertension, were obtained by purposive sampling. Patient data and hypertension grade were obtained from medical records; an auto chemistry analyzer analyzed serum creatinine. Data were analyzed using the Pearson correlation test using SPSS. Participants with hypertension fall into the elderly age (60-69 years), totalling 31 (42%); pre-elderly age (45–59 years) includes 28 (38%); and high-risk elderly age (>70 years) includes 14 (19%). Most of the participants (40 participants) fell into hypertension stage II, followed by hypertension stage I (25 participants), and only 8 participants fell into the elevated category. The mean serum creatinine of participants with Elevated blood pressure criteria was 0.89±0.178, Hypertension grade I 0.91±0.322, and hypertension grade II 0.99±0.269, illustrating a trend of increasing serum creatinine levels due to higher blood pressure criteria. Pearson correlation test shows a significant correlation between both systolic blood pressure with serum creatinine levels (p<0.05, r=0.2) and diastolic blood pressure with serum creatinine levels (p=0.007, r=0.342). There was a trend of increasing serum creatinine levels corresponding to the hypertension grade in participants. Blood pressure was significantly correlated with serum creatinine, clearly confirming that an increase in blood pressure may followed by an increase in serum creatinine.

References

Ameer, O. Z. (2022). Hypertension in chronic kidney disease: What lies behind the scene. Frontiers in Pharmacology, 13(October), 1–28. https://doi.org/10.3389/ fphar.2022.949260

Angeli, F., Gentile, G., Trapasso, M., Verdecchia, P., & Reboldi, G. (2018). Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease. Journal of Human Hypertension, 32(8), 625–632. https://doi.org/10.1038/s41371-018-0081-y

Azwaldi, A., Maksuk, M., Putri Maharani, & Intan Kumalasari. (2023). Determınant factors of hypertensıon ın the elderly at publıc health center ın Palembang, south Sumatera Indonesıa. Epidemiological Journal of Indonesia, 2(1 SE-Article), 1–6. https://journal.paei.or.id/eji/article/view/9

Barreto, E. F., Rule, A. D., Murad, M. H., Kashani, K. B., Lieske, J. C., Erwin, P. J., Steckelberg, J. M., Gajic, O., Reid, J. M., & Kane-Gill, S. L. (2019). Prediction of the Renal Elimination of Drugs With Cystatin C vs Creatinine: A Systematic Review. Mayo Clinic Proceedings, 94(3), 500–514. https://doi.org/10.1016/j. mayocp.2018.08.002

Bozkurt, B., Aguilar, D., Deswal, A., Dunbar, S. B., Francis, G. S., Horwich, T., Jessup, M., Kosiborod, M., Pritchett, A. M., Ramasubbu, K., Rosendorff, C., & Yancy, C. (2016). Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement from the American Heart Association. Circulation, 134(23), e535–e578. https://doi.org/10.1161/CIR.0000000000000 450

Chang, A. R., & Appel, L. J. (2018). Target Blood Pressure for Cardiovascular Disease Prevention in Patients with CKD. Clinical Journal of the American Society of Nephrology : CJASN, 13(10), 1572–1574. https://doi.org/10.2215/CJN.02130218

Duni, A., Dounousi, E., Pavlakou, P., Eleftheriadis, T., & Liakopoulos, V. (2019). Hypertension in Chronic Kidney Disease: Novel Insights. Current Hypertension Reviews, 16(1), 45–54. https://doi.org/10.2174/1573402115666190415153554

Garfinkle, M. A. (2017). Salt and essential hypertension: pathophysiology and implications for treatment. Journal of the American Society of Hypertension, 11(6), 385–391. https://doi.org/10.1016/j.jash.2017.04.006

Ghufron Mukti, A. (2021). Optimalisasi dan pengelolaan penyakit kronis selama pandemi covid-19. BPJS Kesehatan, 3.

Haad, C. R., Pelegrín, C. M., López, A. I. R., & Olmo, R. S. (2023). Hypertension and the kidneys. Medicine (Spain), 13(83), 4875–4882. https://doi.org/10.1016/j.med. 2023.06.017

Harrison, D. G., Coffman, T. M., & Wilcox, C. S. (2021). Pathophysiology of Hypertension: The Mosaic Theory and Beyond. Circulation Research, 128(7), 847–863. https://doi.org/10.1161/CIRCRESAHA.121.318082

Huan, Y., Cohen, D. L., & Townsend, R. R. (2015). Pathophysiology of Hypertension in Chronic Kidney Disease. In Chronic Renal Disease (pp. 163–169). Elsevier Inc. https://doi.org/10.1016/B978-0-12-411602-3.00014-7

Kashani, K., Rosner, M. H., & Ostermann, M. (2020). Creatinine: From physiology to clinical application. European Journal of Internal Medicine, 72(July), 9–14. https://doi.org/10.1016/j.ejim.2019.10.025

Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. In Lembaga Penerbit Balitbangkes.https://repository.badankebijakan.kemkes.go.id/id/eprint/3514/1/Laporan Riskesdas 2018 Nasional.pdf

Luft, F. C. (2021). Biomarkers and predicting acute kidney injury. Acta Physiologica, 231(1), 1–12. https://doi.org/10.1111/apha.13479

Meiriana, A., Trisnantoro, L., & Padmawati, R. S. (2019). Implementasi Program Pengelolaan Penyakit Kronis (Prolanis) Pada Penyakit Hipertensi di Puskesmas Jetis Kota Yogyakarta. Jurnal Kebijakan Kesehatan Indonesia : Jkki Volume, 08(02), 51–58.

Meti, K. ., & Nurjanah, L. S. . (2018). Gambaran Kadar Kreatinin Darah Pada Penderita Hipertensi Lebih Dari 2 Tahun. Prosiding Seminar Nasional Dan Diseminasi Penelitian Kesehatan STIKes Bakti Tunas Husada Tasikmalaya , 3(5), 160–162. http://www.academia.edu/5932965/Hipertensi_dan_Kreatinin

Nappoe, S. A., Djasri, H., & Kurniawan, M. F. (2023). Chronic disease management programme (PROLANIS) in Indonesia: Case study. In Iris.Who.Int. https://iris.who.int/bitstream/handle/10665/373226/9789240079052-eng.pdf?sequence=1

Nuswantoro, A., Aprillia, D., Purwaningsih, I., & Arifa, R. (2022). Profile Of Renal Function Laboratory Examinations In Prolanis Patients In Pontianak City Ari. Jurnal Laboratorium Khatulistiwa, 8(1), 65–68.

Pugh, D., Gallacher, P. J., & Dhaun, N. (2019). Management of Hypertension in Chronic Kidney Disease. Drugs, 79(4), 365–379. https://doi.org/10.1007/s40265-019-1064-1

Purwati N, I., & Indrawati, U. (2017). Pengaruh program pengelolaan penyakıt kronıs (Prolanıs) terhadap penurunan tekanan darah pada pasıen hıpertensı berbasıs teorı carıng. Jurnal Insan Cendekia, 6(1), 1–8.

Qolbi, H. H., Fitriyani, A. W., Wijayanti, S., Fajarulhuda, M., & Maulana, A. R. (2023). 45. Blood Pressure Description in PROLANIS Community in Bandung, West Java. Journal of Hypertension, 41(Suppl 2). https: //journals.lww.com/ jhypertension/fulltext/2023/04002/45__blood_pressure_description_in_prolanis.45.aspx

Rahayu, C., & Indriyani, A. S. (2021). Gambaran Kadar Kreatinin Pada Penderita Hipertensi Di Rumah Sakit Dr.Abdul Radjak Salemba. Anakes : Jurnal Ilmiah Analis Kesehatan, 7(2), 204–216. https://doi.org/10.37012/anakes.v7i2.684

Roche Diagnostics. (2019). Cobas Integra ® 400 plus (Version 3.6) User Manual Version 3.2. file:///D:/school vista/leerjaar 4/stage/examens/CRP/theorie/User manual versie 3.2.pdf

Samartkit, P., & Pullteap, S. (2024). Non-invasive continuous blood pressure sensors in biomedical engineering research: A review. Sensors and Actuators A: Physical, 367, 115084. https://doi.org/10.1016/j.sna.2024.115084

Sulastomo, H., Fauzi, F. A., & Kusumawati, R. (2018). Left Ventricular Hypertrophy dan Fungsi Ginjal pada Penderita Hipertensi. Smart Medical Journal, 1(2).

Vinet, L., & Zhedanov, A. (2011). A “missing” family of classical orthogonal polynomials. Journal of Physics A: Mathematical and Theoretical. https://doi.org/10.1088/1751-8113/44/8/085201

Yusransyah, Halimah, E., & Suwantika, A. A. (2020). Measurement of the Quality of Life of Prolanis Hypertension Patients in Sixteen Primary Healthcare Centers in Pandeglang District, Banten Province, Indonesia, Using EQ-5D-5L Instrument. Patient Preference and Adherence, 14, 1103–1109. https://doi.org/10.2147/PPA.S249085

Yuziani, Y., & Sofia, R. (2023). Correlation between chronic disease management program (prolanis) activities and health status of hypertension patients at Muara Satu community health center, Lhokseumawe city. Jurnal Kedokteran Syiah Kuala, 23(2), 261–268. https://doi.org/10.24815/jks.v23i2.31600

Downloads

Published

2025-01-09

How to Cite

Tanjung, A., Nurhidayah, I. ., Maulidayanti, S., & Br Situmorang, I. M. (2025). Analysis of Serum Creatinine Levels, Blood Pressure and Grade of Hypertension of Chronic Disease Management Program Participants. Medical Laboratory Technology Journal, 10(2), 143–151. https://doi.org/10.31964/mltj.v10i2.619

Issue

Section

Articles